Jesse Rinehart, PhD
Associate ProfessorCards
About
Titles
Associate Professor
Biography
Dr. Jesse Rinehart is an Associate Professor in the Department of Cellular & Molecular Physiology at the Yale University School of Medicine with a joint appointment in the Systems Biology Institute. Dr. Rinehart’s research aims to understand and “decode” the roles of protein phosphorylation in humans. His laboratory uses an innovative combination of quantitative phosphoproteomics and synthetic biology study protein phosphorylation in single proteins and protein networks. Recently, research in Dr. Rinehart’s laboratory has been accelerated by their Escherichia coli based technology that enables site-specific incorporation of phosphoserine into human proteins. Dr. Rinehart received his PhD in Molecular Biophysics and Biochemistry from Yale in 2005. He studied protein synthesis and the evolution of the genetic code during his graduate work with Dr. Dieter Söll. His did his postdoctoral research with Richard Lifton in the Department of Genetics at the Yale University School of Medicine and focused on understanding the role of protein phosphorylation in physiological systems.
Appointments
Cellular & Molecular Physiology
Associate Professor TenurePrimary
Other Departments & Organizations
- Biochemistry, Quantitative Biology, Biophysics and Structural Biology (BQBS)
- Cancer Signaling Networks
- Cellular & Molecular Physiology
- Dean's Workshops
- Diabetes Research Center
- Molecular Medicine, Pharmacology, and Physiology
- Rinehart Lab
- Yale Cancer Center
- Yale Combined Program in the Biological and Biomedical Sciences (BBS)
- Yale Ventures
Education & Training
- PhD
- Yale University School of Medicine (2004)
- MS
- Yale University (1999)
- BA
- Kalamazoo College (1998)
Research
Overview
Medical Research Interests
News & Links
Media
- Featured on the cover of Cell. K-Cl cotransporters (KCCs) control transmembrane electrolyte flux in a variety of physiologic settings, including the acute response to altered extracellular osmolarity. We used targeted phosphoproteomics to reveal how phosphorylation at two conserved sites in KCCs controls their activity.
- Escherichia coli based technology that enables site-specific incorporation of phosphoserine into proteins
News
- December 08, 2021
Lion Heart: an enduring supporter of breast cancer research at Yale
- August 17, 2021Source: Yale West Campus News
Yale Scientists Reveal Molecular Pathway for Smarter Breast Cancer Drugs
- November 02, 2020
New Discoveries About Glucose Metabolism Could Improve Diabetes Treatment
- January 09, 2020
Cellular and Molecular Physiology Annual Retreat 2019